The following is a summary of “Mortality Outcomes with Tenecteplase Versus Alteplase in the Treatment of Massive Pulmonary ...

This medication is an enzyme (tissue plasminogen activator (tPA)), prescribed for heart attack, stroke, and pulmonary embolism. It helps to break down unwanted blood clots. When should Alteplase ...

The activity and sterility of reconstituted alteplase solution and the effectiveness of an alteplase dose-escalation protocol for the clearance of midlinecatheter and central-venous-access device ...

Konstantinides S et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002 Oct 10; 347:1143-50. Goldhaber SZ. Thrombolysis for ...

Alteplase (Activase) is the most common thrombolytic medication used to treat PE. While it carries a low risk of allergic reactions compared with other thrombolytics, the medication is associated ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. This article has ...

Patients with acute pulmonary embolism (PE) have a wide spectrum of clinical presentations, from incidental findings to sudden cardiac death. Management and treatment recommendations in currently ...

The patient was transported to the radiology department connected to a defibrillator and with alteplase prepared for intravenous administration. A chest CT scan with pulmonary embolism protocol ...

PETALING JAYA: Amid the headwinds, the Malaysian private equity (PE) market is set to gain further momentum this year compared with last year as PE firms eye specific sectors, namely healthcare ...

DM 9m was invested in the plant, which will have a capacity of 4,000 tpa, to allow Hoechst to participate in the growing market for A-PET films. Major markets will be in food packaging and medical ...